INS and lipodystrophy: Indeed, metreleptin, the human recombinant leptin analog recently approved for the treatment of metabolic disorders associated with lipodystrophy, has proven to be efficacious at restoring insulin sensitivity and lipids levels7 but failed to restore blood pressure in patients with lipodystrophy42.